Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biotechnology company, has raised $102 million in Series C financing. Biotechnology Value Fund and Redmile Group led the round.
Source: Press Release
Kymera Therapeutics inks $102m Series C
Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biotechnology company, has raised $102 million in Series C financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: